The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Ivan Trifunovich will be occupying the corner office at Helicos BioSciences Corp. (NSDQ:HLCS), as the company rolls out a new licensing program for its single-molecule gene sequencing technology.
Trifunovich, formerly a senior consultant to the Helicos board, was elected to serve as executive chairman Sept. 15. He replaces interim CEO Ronald Lowy, who took over from Stephen Lombardi in February and will remain a board member.
A roundup of personnel changes by medical device, diagnostics and life science companies around the nation:
Medtronic Inc.’s (NYSE:MDT) cardiology group yielded a new director for medical technology company SurModics Inc. (NSDQ:SRDX)
Scott Ward, a former Medtronic senior vice president and president of the company’s CardioVascular business, joined SurModics’ board, bringing its number to nine.
A roundup of personnel changes by medical device, diagnostics and life science companies around the nation:
Aushon BioSystems Inc. created a scientific advisory board to help advise the company on identifying new markets for its multiplex immunoassay platform.
The Billerica, Mass.-based diagnostic equipment maker named Johann de Bono, John Heymach, Gordon Mills and Gavin MacBeath to the board. MacBeath is the co-founder of Cambridge, Mass.-based Merrimack Pharmaceuticals Inc.
Stoughton, Mass.-based STD Med Inc. won $43,000 in workforce development funding from Massachusetts.
The grant is part of $1.3 million in workforce training funds for Bay State.-based companies announced by Gov. Deval Patrick April 27.
Boston Scientific Corp. (NYSE:BSX) shelled out nearly $10 million in cash and just under $40 million in stock awards and options to its two chief executives in 2009, according to regulatory filings.
The payments by the Natick, Mass.-based medical devices giant, made to former CEO James Tobin and his successor, Raymond Elliot, were inflated due to executive compensation triggers in Tobin’s transition and retirement agreement.
Dr. Ron Geraty, CEO at Alere LLC — the health management unit of Inverness Medical Innovations Inc. (NYSE:IMA) — will soon be leaving the company, two years after Alere was acquired by Inverness.
Geraty is expected to step down April 21, although the exact date could be changed by mutual agreement, the company said in a Feb. 19 regulatory filing. No successor was immediately named and Inverness did not disclose why Geraty, 62, was leaving the company.
